Abstract:BACKGROUND:Anti-Müllerian hormone (AMH) is now considered the best serum biomarker of ovarian reserve, while basal sex hormones are classic markers used for assessing ovarian reserve. The interaction between AMH and sex hormones are complicated and not sufficiently addressed. In this study, we took diminished ovarian reserve (DOR) and polycystic ovarian syndrome (PCOS) as two extremes of ovarian reserve (deficient and excessive respectively) to investigate the role of AMH and sex hormones in follicular growth.METHODS:A retrospective cross-sectional survey was performed. The patients assessed AMH and basal sex hormones in the Second Hospital of Zhejiang University from April 2016 to March 2019 were involved in this study. Serum AMH and sex hormone concentrations were tested with electrochemiluminescence method. Stepwise linear regression and binary logistic regression was used to determine the predictors of AMH level and to explore the involved factors determining DOR and PCOS.RESULTS:In the present study, we found that age and follicle-stimulating hormone (FSH) were main negative correlation factors, and luteinizing hormone (LH) and testosterone (T) were main positive factors of AMH. In DOR group, age, FSH and estradiol (E2) increased and T decreased, while in PCOS group, LH and T increased. Binary logistic regression found that age, weight, FSH, E2, and T were the significant factors which independently predicted the likelihood of DOR, and that age, body mass index (BMI), AMH, LH, and T predicted the likelihood of PCOS.CONCLUSIONS:Our study demonstrated that age, FSH, and T were factors that most closely correlated with AMH level, and T was involved in both DOR and PCOS. Since DOR and PCOS are manifested with insufficient AMH and excessive AMH respectively, it is suggested that total testosterone correlated with AMH closely and plays an important role in follicular growth. More attention should be given to testosterone level during controlled ovarian hyperstimulation (COH) process.

Role of epigenetic regulation in diminished ovarian reserve

Downregulation of Homeobox A1 in Human Granulosa Cells is Involved in Diminished Ovarian Reserve Through Promoting Cell Apoptosis and Mitochondrial Dysfunction.

Understanding the Mechanisms of Diminished Ovarian Reserve: Insights from Genetic Variants and Regulatory Factors

Factors Affecting the Live-Birth Rate in Women with Diminished Ovarian Reserve Undergoing IVF-ET

Role of Anti-Müllerian Hormone and Testosterone in Follicular Growth: a Cross-Sectional Study.

Role of lncRNAs in the pathogenic mechanism of human decreased ovarian reserve

Identification of a Mutation in GDF9 As a Novel Cause of Diminished Ovarian Reserve in Young Women

Using Bioinformatics and Metabolomics to Identify Altered Granulosa Cells in Patients with Diminished Ovarian Reserve.

Recent Progress in the Treatment of Women with Diminished Ovarian Reserve

Metabolomic Analysis Reveals Association between Decreased Ovarian Reserve and In Vitro Fertilization Outcomes

Downregulation of glucose-energy metabolism via AMPK signaling pathway in granulosa cells of diminished ovarian reserve patients

Micro-RNAs involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve

Advances in Understanding the Effect and Mechanism of Dehydroepiandrosterone on Diminished Ovarian Reserve

Logistic regression analysis of related factors on diminished ovarian reserve

Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve

Analysis of single-cell RNA sequencing in human oocytes with diminished ovarian reserve uncovers mitochondrial dysregulation and translation deficiency

Diminished ovarian reserve causes adverse ART outcomes attributed to effects on oxygen metabolism function in cumulus cells

Epigenetic regulation in premature ovarian failure: A literature review

Decreased Fatty Acids Induced Granulosa Cell Apoptosis in Patients with Diminished Ovarian Reserve

Exosome-Derived Lncrna LIPE-AS1 for Enhancing Oocytes Maturation and Ameliorating Diminished Ovarian Reserve Through Targeting Mir-330-5p/hdac3 Axis

Targeting Estrogen Receptor Beta Ameliorates Diminished Ovarian Reserve via Suppression of the FOXO3a/Autophagy Pathway